U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07067749) titled 'Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer' on June 10.
Brief Summary: The TEMPO-MIBC trial is a phase III, single-center, two-arm, randomized, controlled trial. Its primary objective is to evaluate the efficacy of a simplified diagnostic and treatment pathway for muscle-invasive bladder cancer (MIBC). This study investigates the role of multiparametric bladder MRI (mpMRI) in patients with biopsy proven cancer of the bladder with clinical features of detrusor muscle invasion. In the experimental arm, enrolled patients will receive a bladder mpMRI, if this exam will confirm the high s...